Haugh, Alexandra
Daud, Adil I. http://orcid.org/0000-0002-6617-8421
Funding for this research was provided by:
Cook Family Foundation
Article History
Accepted: 19 December 2023
First Online: 8 February 2024
Declarations
:
: Funding from the Cook/Juelsgaard and Amoroso Foundation (AD).
: AH declares no conflicts of interest. AD: stock and other ownership interests—Neuvogen, Trex bio. Honoraria—EMD Serono, Inovio Pharmaceuticals. Consulting or advisory role—Genoptix, GlaxoSmithKline, Oncosec, Caris, Eisai, GLG. Speakers' bureau—no relationships to disclose. Research Funding—Bristol-Myers Squibb, Checkmate Pharmaceuticals, Genentech/Roche (Inst), GlaxoSmithKline (Inst), Incyte, Merck/Schering Plough (Inst), Novartis, Oncosec (Inst), Pfizer (Inst).
: Not applicable.
: Not applicable.
: Not applicable.
: No datasets were generated or analyzed during the current study.
: No code was generated.
: Planning and conception AH, AD; writing AH, AD; final editing AH, AD.